EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NDRG1 and its family members: More than just metastasis suppressor proteins and targets of thiosemicarbazones

Mahan Gholam Azad, Tiffany M Russell, Xuanling Gu, Xiao Zhao, Vera Richardson, Tharushi P Wijesinghe, Golap Babu, Xinnong Guo, Busra Kaya, Mahendiran Dharmasivam, Zhao Deng, Des R Richardson

Journal of Biological Chemistry · 2025-07 · 301 (7) · 110230

DOI: 10.1016/j.jbc.2025.110230 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biological Chemistry, 2025-07. Verfasst von Mahan Gholam Azad und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cancer Cell Biology and Drug Discovery, Institute for Biomedicine and Glycomics, Griffith University, Queensland, Australia. Hauptthemen laut MEDLINE: Thiosemicarbazones, Neoplasms, Cell Cycle Proteins, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 308 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, National Health and Medical Research Council, Thrasher Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N-Myc downstream regulated gene-1 (NDRG1) and the other three members of this family (NDRG2, 3, and 4) play various functional roles in the cellular stress response, differentiation, migration, and development. These proteins are involved in regulating key signaling proteins and pathways that are often dysregulated in cancer, such as EGFR, PI3K/AKT, c-Met, and the Wnt pathway. NDRG1 is the primary, well-examined member of the NDRG family and is generally characterized as a metastasis suppressor that inhibits the first step in metastasis, the epithelial-mesenchymal transition. While NDRG1 is well-studied, emerging evidence suggests NDRG2, NDRG3, and NDRG4 also play significant roles in modulating oncogenic signaling and cellular homeostasis. NDRG family members are regulated by multiple mechanisms, including transcriptional control by hypoxia-inducible factors, p53, and Myc, as well as post-translational modifications such as phosphorylation, ubiquitination, and acetylation. Pharmacological targeting of the NDRG family is a therapeutic strategy against cancer. For instance, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) and di-2-pyridylketone-4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC) have been extensively shown to upregulate NDRG1 expression, leading to metastasis suppression and inhibition of tumor growth in multiple cancer models. Similarly, targeting NDRG2 demonstrates its pro-apoptotic and anti-proliferative effects, particularly in glioblastoma and colorectal cancer. This review provides a comprehensive analysis of the structural features, regulatory mechanisms, and biological functions of the NDRG family and their roles in cancer and neurodegenerative diseases. Additionally, NDRG1-4 are explored as therapeutic targets in oncology, focusing on recent advances in anti-cancer agents that induce the expression of these proteins. Implications for future research and clinical applications are also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiosemicarbazonesNeoplasmsCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsTumor Suppressor ProteinsHumansAnimalsNeoplasm MetastasisAntineoplastic AgentsN-myc Downstream-Regulated Gene 1 Protein

Stichwörter der Autor:innen

NDRG1metastasismetastasis suppressionthiosemicarbazone

Substanzen

ThiosemicarbazonesCell Cycle ProteinsIntracellular Signaling Peptides and ProteinsTumor Suppressor ProteinsAntineoplastic AgentsN-myc Downstream-Regulated Gene 1 Protein

Autor:innen und Institutionen

  • Centre for Cancer Cell Biology and Drug Discovery, Institute for Biomedicine and Glycomics, Griffith University, Queensland, Australia.
  • Centre for Cancer Cell Biology and Drug Discovery, Institute for Biomedicine and Glycomics, Griffith University, Queensland, Australia; Department of Pathology and Biological Responses, Nagoya University Graduate School…

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
  • National Health and Medical Research Council
  • Thrasher Research Fund
  • National Breast Cancer Foundation
  • Tour de Cure
  • Griffith University
  • Australian Research Council

Zitieren

APA

Azad, M. G., Russell, T. M., Gu, X., Zhao, X., Richardson, V., Wijesinghe, T. P., Babu, G., Guo, X., Kaya, B., Dharmasivam, M., Deng, Z., & Richardson, D. R. (2025). NDRG1 and its family members: More than just metastasis suppressor proteins and targets of thiosemicarbazones. Journal of Biological Chemistry, 301(7), 110230. https://doi.org/10.1016/j.jbc.2025.110230

Vancouver

Azad MG, Russell TM, Gu X, Zhao X, Richardson V, Wijesinghe TP, et al. NDRG1 and its family members: More than just metastasis suppressor proteins and targets of thiosemicarbazones. Journal of Biological Chemistry. 2025;301(7):110230. doi:10.1016/j.jbc.2025.110230

BibTeX
@article{Azad2025,
  author = {Azad, Mahan Gholam and Russell, Tiffany M and Gu, Xuanling and Zhao, Xiao and Richardson, Vera and Wijesinghe, Tharushi P and Babu, Golap and Guo, Xinnong and Kaya, Busra and Dharmasivam, Mahendiran and Deng, Zhao and Richardson, Des R},
  title = {NDRG1 and its family members: More than just metastasis suppressor proteins and targets of thiosemicarbazones},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {7},
  pages = {110230},
  doi = {10.1016/j.jbc.2025.110230}
}
Kostenlos starten →